Introduction
============

Patients with acute or decompensated chronic abdominal diseases can develop acute respiratory insufficiency, the etiology of which is difficult to identify. The difficulty arises because the condition is a result of acute respiratory failure, which is caused by an inflammatory response that is secondary to the abdominal pathology or that is due to nosocomial pneumonia \[[@B1],[@B2]\]. In this context, the diagnosis of an abdominal or lung infection can be complicated by several factors: (a) the systemic signs and symptoms of infection are non-specific, (b) the clinical data and the radiographic findings within the context of the patient in the intensive care unit (ICU) do not provide high specificity for either of the possibilities, and (c) the microbiological findings can be altered by previous antibiotic use. Hence, the therapeutic attitude, the management of the patient, and the prognosis would depend heavily on the identification of the focus of the infection.

The use of markers of systemic inflammation in the diagnosis and in therapeutic decision-making is progressively more valuable in clinical practice \[[@B3]\]. One of the more frequent applications is in the differential diagnosis between the inflammatory pictures of infection versus non-infection \[[@B4]\]. However, the measurement of inflammation markers in the circulation does not identify the focus of the infection \[[@B5]\]. Determinations of C-reactive protein or procalcitonin (PCT) in the alveolar fluid have been useless to diagnose infection as cytokines \[[@B6]-[@B8]\]. Conversely, the measurement of the triggering receptor expressed on myeloid cells 1 (TREM-1) in alveolar, pleural, sinovial, and cerebrospinal fluids has, indeed, been demonstrated to be useful in several studies \[[@B5],[@B9]-[@B12]\]. Also, an increase in TREM-1 has been observed in peritoneal fluid following the induction of peritonitis in an animal model \[[@B13]\].

Our hypothesis for this study is that the determination of soluble TREM-1 (sTREM-1) in alveolar and peritoneal fluids in seriously ill patients with abdominal diseases and respiratory insufficiency could be useful in identifying the existence of an infection. It is plausible that the local increase in sTREM-1 would be higher in the presence of infection, and this would enable us to distinguish pulmonary or extrapulmonary infection as the etiology of acute respiratory failure.

The objective of the present study was to investigate the diagnostic value of sTREM in bronchoalveolar lavage and peritoneal fluid in patients admitted to the ICU with severe respiratory insufficiency and an abdominal disease. We wished, as a secondary objective, to compare the diagnostic value of cutoff points of sTREM in both of these biological fluids.

Materials and methods
=====================

Design of the study
-------------------

We conducted a prospective observation study of consecutive cases.

Study site and subjects
-----------------------

The study was conducted in the ICU for a period of 18 months. The patients selected needed to fulfill the following criteria: (a) acute abdominal pathology, (b) respiratory insufficiency with acute respiratory distress syndrome (ARDS) criteria of not more than 3 days in duration, and (c) admission to the ICU. We excluded patients in whom it was not possible to extract a sample of peritoneal fluid. The protocol was reviewed and approved by the local ethics committee, and the patients (or their relatives) provided informed consent to participation in the study. The written consent included the permission to collect and publish (anonymously) personal data concerning the patients.

Protocol for data collection
----------------------------

The following data were collected: age, gender, chronic diseases, vital signs, Acute Physiology Score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score \[[@B14]\], Sepsis-related Organ Failure Assessment (SOFA) score \[[@B15]\], presence or absence of systemic inflammatory response syndrome \[[@B16]\], data on gas exchange and the mode of mechanical ventilation, radiological assessments, and the score on the modified Clinical Pulmonary Infection Score (CPIS) \[[@B17]\]. With respect to the abdomen, data were collected via physical examination, and the intra-abdominal pressure was measured via vesical probe. Other data included radiological assessments, intraoperative findings, blood chemistry, and microbiology laboratory findings. With respect to the lung, data were collected on the macroscopic aspects of the respiratory secretions, the Gram bacteria staining of mini-bronchoalveolar lavage (mini-BAL) fluid sent to the microbiology laboratory, and the quantitative isolations in culture.

Definitions
-----------

Diagnosis of hospital-acquired pneumonia, the pneumonia associated with mechanical ventilation, or pneumonia related to the health-care provision was conducted in accordance with the criteria recommended by the American Thoracic Society and the Infectious Diseases Society of America \[[@B18]\]. The diagnosis of the abdominal infection focus was performed in accordance with the Centers for Disease Control and Prevention (Atlanta, GA, USA) criteria for gastrointestinal infection and for infections associated with surgery \[[@B19]\].

Collection and processing of the isolated abdominal fluid
---------------------------------------------------------

Fine-needle aspiration puncture was performed under echographic guidance by experienced interventional radiologists. After vortex mixing, the sample was separated into three aliquots: the first was stored at -70°C until required for analysis, the second was sent for cytobiochemical analyses, and the third was sent to the microbiology laboratory.

Collection and processing of the alveolar liquid
------------------------------------------------

The sample of alveolar liquid was obtained using a small (20 mL of physiologic saline) volume of bronchoalveolar lavage (mini-BAL) \[[@B20]\]. After vortex mixing, the sample was centrifuged into two phases: the supernatant was separated and frozen at -70°C until required for analyses, and the infranatant was sent to the microbiology laboratory. The cutoff value of mini-BAL for the diagnosis of lung infection was 10^3^colony-forming units per milliliter.

Measurement of inflammation markers
-----------------------------------

Serum PCT was measured with time-resolved amplified cryptate emission (TRACE) technology in a Kryptor analyzer (Brahms Diagnostica, Berlin, Germany). The sTREM-1 was determined by immunoassay with a combination monoclonal/polyclonal antibody of the IgG1 type raised against TREM-1 (R&D Systems, Inc., Minneapolis, MN, USA). The assay was performed in accordance with the instructions of the manufacturer.

Statistical analyses
--------------------

All statistical analyses were performed with SPSS version 15 software (SPSS, Inc., Chicago, IL, USA). The χ^2^test was used for categorical variables, and the Student *t*or Mann-Whitney test was used for continuous variables. The values for PCT and sTREM-1 were expressed as medians with the interquartile ranges (25% to 75%) in parenthesis. Diagnostic capacities of alveolar sTREM-1, peritoneal sTREM-1, and the alveolar-to-peritoneal sTREM-1 ratios were evaluated with the receiver operating characteristic curves. Sensitivity and specificity as well as positive (PPV) and negative (NPV) predictive values were calculated.

Results
=======

Twenty-two patients fulfilled the inclusion criteria. One patient was censored because of our inability to obtain abdominal fluid. The mean age (± standard deviation) was 48.2 ± 16.7 years, and 57% (*n*= 12) were males. Eleven patients (52%) had a chronic abdominal disease, seven patients (33%) had hepatic cirrhosis, and one patient each had intestinal graft-versus-host disease, Budd-Chiari syndrome, cystic fibrosis, and intestinal lymphoma. The acute abdominal diseases diagnosed were spontaneous bacterial peritonitis in 29% of cases, acute enteritis in 19%, acute pancreatitis in 14%, digestive tract hemorrhage in 14%, and acute hepatitis in 10%, and 1 case each (5%) had cholecystitis, hepatic abscess, and intestinal subocclusion. The mean score on the APACHE II scale on the day of admission to the ICU was 18.6 ± 5.8 points. The intra-ICU mortality was 76.2%. Table [1](#T1){ref-type="table"} shows the individual characteristics of the patients in the study.

###### 

Baseline characteristics of the patients

  Case   Chronic abdominal pathology   Other complaints                Admission to hospital           APACHE II score   Exitus
  ------ ----------------------------- ------------------------------- ------------------------------- ----------------- --------
  1      No                            No                              Hepatic lesions                 13                Yes
  3      Intestinal GVHD               Acute myeloid leukemia          Sepsis                          15                Yes
  4      Hepatic cirrhosis             No                              Gastrointestinal bleeding       24                Yes
  5      No                            Acute lymphatic leukemia        Enteritis                       19                
  6      No                            No                              Acute pancreatitis              18                No
  7      Hepatic cirrhosis             AIDS                            Gastrointestinal bleeding       21                Yes
  8      Hepatic cirrhosis             No                              Gastrointestinal bleeding       20                No
  9      Budd-Chiari syndrome          No                              Respiratory failure             10                Yes
  10     No                            No                              Acute pancreatitis              20                Yes
  11     No                            No                              Intestinal subocclusion         25                No
  12     No                            Alcoholism                      Acute pancreatitis              23                Yes
  13     No                            AIDS                            Acute hepatitis                 12                Yes
  14     No                            No                              Paralyzed ileum                                   Yes
  15     Hepatic cirrhosis             AIDS                            Hydropic decompensation         29                Yes
  16     No                            Acute myeloid leukemia          Sepsis                          19                Yes
  17     Cystic fibrosis               Hepato-bipulmonary transplant   Hepato-bipulmonary transplant   9                 Yes
  18     Hepatic cirrhosis             No                              Cholecystitis                   11                No
  19     Intestinal lymphoma           No                              Acute hepatitis                 14                No
  20     No                            No                              Acute pancreatitis              25                Yes
  21     Hepatic cirrhosis             No                              Gastrointestinal bleeding       19                Yes
  22     Hepatic cirrhosis             No                              Hydropic decompensation         26                Yes

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. APACHE II, Acute Physiology and Chronic Health Evaluation II; GVHD, graft-versus-host disease.

General characteristics upon entry into the study
-------------------------------------------------

The mean stay in the ICU was 4.04 ± 2.3 days, and the mean duration of ventilation was 2.85 ± 1.2 days. The mean body temperature was 38.3 ± 1°C, the leukocytes were 10,176 ± 6,736 cells/mL (median 11,600, range 4,600 to 13,650), and the plasma PCT was 17.77 ± 25.42 ng/mL (median 7.9, range 1.84 to 18.96). The mean SOFA score was 12.8 ± 3.4 points. All of the cases required wide-spectrum antibiotic treatment and invasive mechanical ventilation with an elevated fraction of inspired oxygen (FiO~2~= 0.7 ± 0.2 and positive end-expiratory pressure = 9 ± 2.5 mm Hg). Fourteen patients (66.7%) were in shock with a need for vasoactive drugs, and four (19%) underwent the technique of continuous renal replacement therapy (Table [2](#T2){ref-type="table"}).

###### 

Characteristics of the patients upon inclusion in the study

  Case   SOFA score   Antibiotics   Vasoactive drugs   CRRT   Procalcitonin, ng/mL   Temperature, °C   Leukocytes,/mm^3^   Final diagnosis
  ------ ------------ ------------- ------------------ ------ ---------------------- ----------------- ------------------- -----------------------------
  1      11           Yes           Yes                No     96.46                  39.0              9,800               Systemic infection^a^
  3      14           Yes           Yes                No     40.9                   37.0              1,100               Systemic infection^b^
  4      12           Yes           No                 No     1.28                   36.4              7,600               VAP
  5      16           Yes           No                 No     18.62                  40.0              0                   Enteritis + VAP
  6      12           Yes           Yes                Yes    15.0                   38.6              21,200              VAP + infected pancreatitis
  7      13           Yes           Yes                No     3,054                  38.8              11,700              Nosocomial pneumonia
  8      16           Yes           Yes                No     3.5                    39.0              2,900               VAP
  9      14           Yes           Yes                No     10.38                  28.0              20,400              HAP
  10     15           Yes           Yes                Yes    50.0                   38.0              11,600              VAP + infected pancreatitis
  11     9            Yes           Yes                No     4.53                   37.8              14,100              VAP
  12     11           Yes           No                 Yes    13.0                   38.2              7,600               Infected pancreatitis
  13     11           Yes           No                 No     0.833                  38.0              12,700              SBP
  14     11           Yes           Yes                No     68.65                  40.0              13,200              Enteritis
  15     21           Yes           Yes                No     19.3                   37.6              12,400              SBP
  16     16           Yes           Yes                No     7.9                    39.3              200                 Enteritis
  17     6            Yes           No                 No     0.784                  36.0              6,600               Systemic infection^c^
  18     7            Yes           No                 No     0.49                   38.8              11,900              HAP
  19     16           Yes           Yes                No     0.90                   37.0              6,100               HAP
  20     12           Yes           Yes                Yes    10.74                  38.8              23,200              VAP
  21     12           Yes           No                 No     2.41                   38.7              3,100               VAP
  22     14           Yes           Yes                No     4.44                   38.0              16,300              VAP + SBP

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. \'Systemic infection\' indicates that the same infection affected both the abdomen and lungs: ^a^septic thrombophlebitis of the portal vein by *Salmonella tiphy*with hematogenous pneumonia; ^b^citomegaloviruses colitis and pneumonia; ^c^systemic infection (lung + abdominal) by *Aspergillus fumigates*. CRRT, continuous renal replacement therapy; HAP, hospital-acquired pneumonia; SBP, spontaneous bacterial peritonitis; SOFA, Sepsis-related Organ Failure Assessment; VAP, ventilator-associated pneumonia.

Respiratory characteristics at the time of inclusion in the study
-----------------------------------------------------------------

The mean score on the CPIS was 5.4 ± 2.4 points (median 6, range 3 to 7). The mean parameters of gas exchange were pH = 7.33 ± 0.11, partial pressure of oxygen (pO~2~) = 42.2 ± 12.7 mm Hg, partial pressure of carbon dioxide (pCO~2~) = 82.9 ± 28.3 mm Hg, bicarbonate = 19.9 ± 3.3 mmol/L, and arterial partial pressure of oxygen (PaO~2~)/FiO~2~ratio = 122.7 ± 43.4. Radiological findings were 8 localized condensations (38%), 11 diffuse interstitial infiltrate (52.5%), and 2 pleural effusions (9.5%). Sixteen patients (76%) had a definitive diagnosis of pulmonary infection: 7 of them also had an abdominal infection (in 5 of these, the infection was systemic and caused by the same microorganism). The median alveolar sTREM-1 was 1,437 (range 656 to 2,512) pg/mL (Table [3](#T3){ref-type="table"}).

###### 

Respiratory characteristics of the patients

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case   Days under invasive MV   PaO~2~/FiO~2~   Chest x-ray                  CPIS   Alveolar\                   Alveolar sTREM-1, pg/mL   Lung infection   Type of infection
                                                                                      microbiology                                                           
  ------ ------------------------ --------------- ---------------------------- ------ --------------------------- ------------------------- ---------------- -------------------
  1      3                        167             Diffused interstitial        3      *Salmonella tiphy*          1,437                     Yes              HAP

  3      1                        111             Diffused interstitial        3      CMV                         434                       Yes              HAP

  4      2                        83              Diffused interstitial        6      *Acinetobacter baumannii*   2,475                     Yes              HAP

  5      7                        69              LRL condensation             8      *A. baumannii*              430                       Yes              VAP

  6      6                        180             LLL condensation             6      *A. baumannii*              2,166                     Yes              VAP

  7      4                        80              Bilateral infiltrate         6      *Escherichia coli*          1,755                     Yes              HAP

  8      2                        172             Diffused interstitial        5      *Staphylococcus aureus*     3,322                     Yes              HAP

  9      2                        111             Pulmonary condensation, R    7      *Aspergillus fumigatus*     3,399                     Yes              HAP

  10     3                        108             Bilateral infiltrate         6      *Haemophilus influenzae*    3,758                     Yes              VAP

  11     4                        190             LRL condensation             6      *E. coli*                   1,167                     Yes              HAP

  12     2                        93              Bilateral infiltrate         1      Negative                    862                       No               

  13     3                        132             Pleural effusion, R          2      Negative                    229                       No               

  14     1                        160             Diffused interstitial        4      Negative                    883                       No               

  15     1                        91              Diffused interstitial        4      *Candida albicans*          1,139                     No               

  16     1                        64              Diffused interstitial        4      Negative                    437                       No               

  17     1                        195             Diffused interstitial        3      *A. fumigatus*              2,382                     Yes              HAP

  18     1                        125             Bilateral pleural effusion   9      *Pseudomonas aeruginosa*    175                       Yes              HAP

  19     2                        130             Bi-basal condensation        5      *A. fumigatus*              2,550                     Yes              HAP

  20     6                        58              Pulmonary condensation, L    8      *P. aeruginosa*             958                       Yes              VAP

  21     6                        95              LRL condensation             7      *A. baumannii*              450                       Yes              VAP

  22     2                        163             LRL condensation             8      *S. aureus*                 3,986                     Yes              HAP
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. CPIS, Clinical Pulmonary Infection Score; HAP, hospital-acquired pneumonia; L, left; LLL, lower left lobe; LRL, lower right lobe; MV, mechanical ventilation; PaO~2~/FiO~2~, arterial partial pressure of oxygen/fraction of inspired oxygen; R, right; VAP, ventilator-associated pneumonia.

Abdominal characteristics on the day of inclusion in the study
--------------------------------------------------------------

The mean level of glucose in the peritoneal fluid was 157.64 ± 77 mg/dL (median 161, range 104 to 330), and the mean of neutrophils was 406.5 ± 1,108 cells/mm^3^(median 51, range 10 to 249). The mean intra-abdominal pressure was 15.06 mm Hg. The diagnosis of abdominal infection was established in 12 patients (57%); in 7 of these patients, the diagnosis of lung infection was established as well. The median value of s-TREM in peritoneal fluid was 933 (range 305 to 2,560) pg/mL (Table [4](#T4){ref-type="table"}).

###### 

Abdominal characteristics of the patients

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case   IAP, mm Hg   Neutrophils in peritoneal fluid, mm^3^   Glucose in peritoneal fluid, mg/dL   Peritoneal fluid microbiology   Peritoneal sTREM-1, pg/mL   Abdominal infection   Type of infection
  ------ ------------ ---------------------------------------- ------------------------------------ ------------------------------- --------------------------- --------------------- ----------------------
  1                   130                                                                           *Salmonella tiphy*              305                         Yes                   Hepatic abscesses

  3      15           1,670                                    228                                  Polymicrobial                   2,871                       Yes                   Colitis CMV

  4      18           0                                        179                                  Negative                        482                         No                    

  5      18                                                                                         *Acinetobacter baumannii*       935                         Yes                   Enteritis

  6                   103                                      154                                  *A. baumannii*                  1,242                       Yes                   Pancreatic infection

  7      18           10                                       238                                  Negative                        445                         No                    

  8                   10                                       128                                  Negative                        288                         No                    

  9      13           30                                       45                                   Negative                        459                         No                    

  10     22           12,700                                                                        Negative                        3,474                       Yes                   Pancreatic infection

  11                  16                                       248                                  Negative                        227                         No                    

  12     15           0                                        127                                  *Enterococcus faecalis*         3,267                       Yes                   Pancreatic infection

  13     11           544                                      93                                   Negative                        1,423                       Yes                   SBP

  14     11                                                                                         Negative                        2,250                       Yes                   Enteritis^a^

  15     7            462                                      34                                   Negative                        1,633                       Yes                   SBP

  16     17           0                                        186                                  Negative                        933                         Yes                   Enteritis^b^

  17                                                                                                *Candida krusei*,\              3,634                       Yes                   Enteritis^c^
                                                                                                    *Enterococcus faecium*                                                            

  18     11           51                                       169                                  Negative                        305                         No                    

  19     25           249                                      108                                  Negative                        301                         No                    

  20     14           10                                                                            Negative                        854                         No                    

  21     14           148                                      285                                  Negative                        174                         No                    

  22     12           4,365                                    30                                   *Escherichia coli*              4,406                       Yes                   SBP
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. ^a^Diagnosed from surgical findings; ^b^diagnosed from necropsy findings; ^c^clinical and microbiological diagnoses. CMV, cytomegalovirus; IAP, intra-abdominal pressure; SBP, spontaneous bacterial peritonitis; sTREM-1, soluble triggering receptor expressed on myeloid cells 1.

Capacities of A-sTREM and P-sTREM to diagnose lung and abdominal infections, respectively
-----------------------------------------------------------------------------------------

Nine patients had lung infection (without abdominal infection), 5 had abdominal infection (without lung infection), and 7 had both infections. The patients with lung infection had a higher CPIS and a greater alveolar sTREM-1 (*P*= 0.019 and *P*= 0.019, respectively) compared with those without lung infection. The patients with abdominal infection had a lower CPIS and increased plasma PCT and peritoneal sTREM (*P*= 0.002, *P*= 0.018, *P*\< 0.001, respectively) compared with those without abdominal infection (Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}).

###### 

Identification of pulmonary (alveolar) and abdominal (peritoneal) infection

                     Lung infection       Abdominal infection                                                       
  ------------------ -------------------- --------------------- ------- --------------------- --------------------- ---------
  CPIS               6.5 (3.7-7.7)        4 (1.5-4.5)           0.019   3.5 (3.5-5.7)         7 (6-8)               0.002
  Serum PCT, ng/mL   4.5 (1.9-16.8)       13 (7.9-19.3)         0.409   16.8 (6.2-45.4)       3.05 (6-8)            0.018
  A-sTREM, pg/mL     1,963 (1,010-3,129   862 (333-1,011)       0.019   1,011 (435-2,274)     1,760 (1,167-2,550)   0.177
  P-sTREM, pg/mL     470 (303-2056)       1,633 (1,423-2,250)   0.117   1,941 (1,088-3,370)   305 (288-459)         \<0.001

A-sTREM, alveolar soluble triggering receptor expressed on myeloid cells; CPIS, Clinical Pulmonary Infection Score; PCT, procalcitonin; P-sTREM, peritoneal soluble triggering receptor expressed on myeloid cells.

###### 

Diagnostic capacity of alveolar sTREM and peritoneal sTREM

                              Abdominal infection   Lung infection
  --------------------------- --------------------- ----------------
  Sensitivity                 92%                   81%
  Specificity                 100%                  80%
  Positive predictive value   100%                  93%
  Negative predictive value   90%                   57%
  Area under the curve        0.903 (0.078)         0.775 (0.124)

sTREM, soluble triggering receptor expressed on myeloid cells.

The best cutoff point of alveolar sTREM for the diagnosis of lung infection was 900 pg/mL (sensitivity 81%, specificity 80%, PPV 93%, NPV 57%, and area under the curve \[AUC\] 0.775). In abdominal infection, the best cutoff point of peritoneal sTREM was 900 pg/mL (sensitivity 92%, specificity 100%, PPV 100%, NPV 90%, and AUC 0.903).

Diagnostic capacity of the alveolar-to-peritoneal sTREM ratio to discriminate the infection focus
-------------------------------------------------------------------------------------------------

Nine patients had lung infection (without abdominal infection), 5 had abdominal infection (without lung infection), and 7 had both infections. All patients with just lung infection had an alveolar-to-peritoneal sTREM ratio of greater than 1, and all patients with just abdominal infection had an alveolar-to-peritoneal sTREM ratio of less than 1. However, patients with both infections had a huge variability, preempting any effective clinical application of the ratio.

Discussion
==========

The results of our study demonstrate the usefulness (high predictive value) of measuring sTREM-1 in alveolar and peritoneal fluids in the diagnosis of pulmonary or abdominal infection (or both) in the context of ARDS. A-sTREM-1 was able to identify pneumonia as a pathogenic factor for ARDS. The relationships between the alveolar and peritoneal sTREM-1 values identified the focus of the infection.

The application of the sTREM-1 measurement for diagnosing pulmonary infections has had conflicting results. In the original study by Gibot and colleagues \[[@B5]\] and in subsequent studies \[[@B10]\], the measurement of alveolar sTREM achieved good results. Gibot and colleagues \[[@B5]\] found an area under the receiver operating characteristic curve for alveolar sTREM-1 of 0.93 (95% confidence interval 0.92 to 0.95) in patients with community-acquired pneumonia or ventilator-associated pneumonia (VAP). In their study, Determann and colleagues \[[@B10]\] established a cutoff of 200 pg/mL of alveolar sTREM-1 with a sensibility of 75% and a specificity of 84% in the diagnosis of VAP. More recent studies by Anand and colleagues \[[@B21]\] and by others \[[@B22]\] did not reach the same conclusions. The discordance in the findings could be due to differences in the techniques for alveolar sample acquisition, in the method of measurement of sTREM-1, or in the type of patients included in the study. Anand and colleagues \[[@B21]\] segregated their patient population as those without VAP (*n*= 21), with definite VAP (*n*= 19), with indefinite VAP (*n*= 56), and with alveolar hemorrhage (*n*= 9) and analyzed only the first two of these groups. Although the group with VAP showed higher levels of sTREM-1 (171.9 ± 158.7 pg/mL) than the group without VAP (96.7 ± 76.2 pg/mL), this difference did not reach statistical significance (*P*= 0.06) \[[@B21]\]. In our study, the patients with lung infection had a higher level of alveolar sTREM than the patients without lung infection (mean 1,963 pg/mL, interquartile range 1,010 to 3,129 versus 862 pg/mL, interquartile range 333 to 1,011; *P*= 0.019). Of note is that the values of sTREM-1 observed in our study do not compare with those observed by Anand and colleagues \[[@B21]\], who used the same analytical method as we did (that is, enzyme-linked immunoabsorbent assay). The differences could be due to the extreme status of our patient population (SOFA score 12.8 ± 3.4); the study of Anand and colleagues does not report SOFA score. With a cutoff point of 900 pg/mL, the specificity is high and the PPV reaches 100%.

The measurement of sTREM-1 in peritoneal fluid as a diagnostic method has been less studied. It has been tested in an animal model in which the induction of peritonitis provoked an increase in the sTREM-1 in peritoneal fluid \[[@B13]\]. Recently, Determann and colleagues \[[@B23]\] analyzed the capacity of peritoneal sTREM-1 to diagnose the persistence of secondary peritonitis post-surgery. The authors, in a sequential study of sTREM-1, observed that the patients with persistent infection at 48 hours post-surgery had a significantly higher median sTREM-1 (319 versus 85 pg/mL; *P*= 0.001). We confirmed that patients with abdominal infection had elevated levels of peritoneal sTREM-1 of 1,941 pg/mL (interquartile range 1,088 to 3,370) versus 305 pg/mL (interquartile range 288 to 459) (*P*\< 0.001). Furthermore, with a cutoff point of at least 900 pg/mL, the diagnostic value showed high sensitivity (92%), specificity (100%), PPV (100%), and NPV (90%).

As expected, body temperature and plasma leukocyte counts were ineffective in identifying the infection focus. Elevated levels of plasma PCT were associated with abdominal infection, whereas 60% of the patients with pulmonary infection had a serum PCT level of less than 2.5 ng/mL.

In our study, we used the measurement of sTREM-1 in alveolar and peritoneal fluids to discriminate the etiology of acute respiratory failure. However, the relatively high percentage of patients who have a systemic infection coexisting with abdominal and pulmonary infections complicates this objective. All patients with lung infection alone had an alveolar-to-peritoneal sTREM ratio of greater than 1, and all patients with abdominal infection alone had an alveolar-to-peritoneal sTREM ratio of less than 1. However, patients with both infections had a huge variability, preempting an effective clinical application of the ratio.

The principal limitation of our study is the small sample size. This important limitation, which precludes the generalization of the findings, is partially balanced by the novelty of the two aspects of the study design (that is, the application of sTREM-1 to the diagnosis of abdominal infection and the concomitant determination of the sTREM-1 in two different sites to establish the infection focus). Our results need to be corroborated in a study with a larger sample size. The second limitation is the heterogeneity of our cohort. We included neutropenic patients in whom the usefulness of sTREM-1 has not been established. However, in our neutropenic patients, peritoneal and alveolar sTREM-1 levels showed results similar to those in non-neutropenic patients. Although the diagnosis of infection had been performed in accordance with established criteria, the microbiology results could have been affected by the generalized use of broad-spectrum antibiotics.

Conclusions
===========

The results of our study show that the measurement of sTREM-1 is useful in the diagnosis of pulmonary infection and of abdominal infection in the context of severe acute respiratory failure. Further studies with a larger sample sizes are fully warranted to confirm the usefulness of sTREM-1 found in this preliminary study. Moreover, on the basis of our findings, the accuracy of this marker in neutropenic patients should be explored.

Key messages
============

• Alveolar soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) is useful in diagnosing lung infections in the context of acute respiratory distress syndrome.

• Peritoneal sTREM-1 is capable of identifying an abdominal infection, including those developed in the setting of a chronic abdominal disease as spontaneous bacterial peritonitis in patients with hepatic cirrhosis.

• sTREM-1 seems to be the ideal biomarker to identify the site of infection in critical care patients when measured in fluids coming from the suspected tissues.
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